SEARCH
Tynax ~ Patent Library

Patent for Sale:

Implantable Drug Delivery Pump    

A fail-safe refill process for implantable drug delivery pumps. Patients or home care-giver can safely refill pump without having to visit physician office.

Overview

Patents that solve a significant market need in the treatment of chronic diseases. The market for these inventions is at least $195M US and $3B worldwide.

As the number of patients with chronic pain, osteoporosis, diabetes and other chronic diseases continues to grow, more and more patients will use drug delivery pumps to aid compliance. Patients with chronic pain, diabetes, and Parkinson’s, have benefitted by using a pump to automatically deliver their needed medication. These pumps are generally worn externally, necessitating penetration of the skin with a needle to deliver the medication into the body. To avoid injection-site complications, this needle must be moved to a new location, usually, at least once every three days. The discomfort and inconvenience of moving the needle frequently can be overcome if the patient uses an implanted pump. The seller has recently solved a major problem with implantable drug delivery pumps that will make implanted pumps more desirable.

Currently patients must visit a professional healthcare provider to have an implanted pump refilled. The seller has developed an implantable drug delivery pump with a fail-safe refill system enabling patients, or their home healthcare providers, to refill their pumps without having to leave their home. This ability to safely refill an implanted drug delivery pump by the patient or home caregiver will significantly reduce healthcare costs and greatly improve patient quality of life.

Two already-issued US patents and one pending EPO patent application protect the fail-safe refill system. The pending EPO patent application, filed in 2010, will extend this protection to countries in Europe has not yet been examined.

The technology can be used to treat many chronic diseases, such as chronic pain, osteoporosis, diabetes, alzheimer’s, epilepsy, and Parkinson’s, disease. Alternatively, pump manufacturers could adapt this game-changing refill process to their own drug delivery devices to treat any of these or other chronic diseases.

Primary Application of the Technology

Continuous drug delivery to patients having a chronic disease requiring frequent medication.

The primary target market for this technology is a device, or possibly drug, manufacturer focused on chronic diseases such as "chronic pain", diabetes, osteoporosis, alzheimer's, epilepsy and "parkinson disease".

The Problem Solved by the Technology

Safely refilling an implanted drug delivery pump by patients, or their home-care provider, in lieu of having to visit a physician office. Patients could visit their physician's office each time the pump must be refilled but this is inconvenient and much more expensive than self-filling by the patient. Another alternative is for a nurse or other qualified professional refill the implanted pump at the patient's home but this also is much more expensive than having the patient, or home care-giver refill the pump as needed.

How the Technology Solves the Problem

Currently a drug delivery pump is refilled by a physician injecting the drug into the pump. Such a refill system requires a professional to refill the pump. In the seller's system, the patient (or home care-giver) inserts a needle attached to a refill vial that has no plunger. Instead, refill with this system will not occur unless the needle is inserted properly into the refill septum of the drug delivery pump. Upon proper insertion, the pump is activated and medication is withdrawn from the refill vial by the pump motor and transferred into the pump drug reservoir. If the needle is not inserted into the proper location the pump will not be activated and no medication will be transferred.

Competitive Advantage

Currently patients must visit a professional healthcare provider to have an implanted pump refilled. The seller has invented an implantable pump with a fail-safe refill system enabling patients, or their home healthcaare provider, to refill their pump without having to leave home. This ability to safely refill an implanted drug delivery pump by the patient or home care-giver will greatly improve patient quality of life and reduce overall healthcare costs. No other such fail-safe refill system been published or patented.

The seller may consider selling these patents individually.

Frequently Asked Questions

Is there a working prototype?
Not at this time.

Can this refill system be adapted to a manufacturer's existing drug delivery device?
In most cases, yes.

Patent Summary

U.S. Patent Classes & Classifications Covered in this listing:

Class 604: Surgery


Class 1: